Acquisition gives French biomanufacturer upstream and downstream solutions

July 15, 2009

LCGC Europe eNews

LCGC Europe eNews-07-10-2009, Volume 0, Issue 0

Novasep has announced the acquisition of Henogen, a contract manufacturing organization offering bioprocess development and manufacturing services from the cell bank to the supply of clinical products. The move adds a range of upstream processing capabilities and services to Novasep?s current downstream offerings.

Novasep has announced the acquisition of Henogen, a contract manufacturing organization offering bioprocess development and manufacturing services from the cell bank to the supply of clinical products. The move adds a range of upstream processing capabilities and services to Novasep’s current downstream offerings.

The company now offers a combination of solutions for biopharmaceutical manufacturing. These include insourcing solutions, such as chromatography and membrane filtration technologies and complete downstream processing from lab to industrial scale, as well as outsourcing solutions including contract biomanufacturing services from the cell bank to the vial.

"Novasep is making another strategic step forward with the acquisition of Henogen," said Dr Roger-Marc Nicoud, president and CEO of the company. "The two companies have an excellent range of complementary capabilities and we look forward to offering our customers an even wider range of manufacturing services."

For more information visit the company’s website at www.novasep.com